INCIDENCE, COURSE, AND SEVERITY OF DELAYED NAUSEA AND VOMITING FOLLOWING THE ADMINISTRATION OF HIGH-DOSE CISPLATIN

被引：298
作者：
KRIS, MG
GRALLA, RJ
CLARK, RA
TYSON, LB
OCONNELL, JP
WERTHEIM, MS
KELSEN, DP
机构：
[1] MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
[2] CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1985年 / 3卷 / 10期
关键词：
D O I：
10.1200/JCO.1985.3.10.1379
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1379 / 1384
页数：6
相关论文
共 25 条
  • [1] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE
    AAPRO, MS
    PLEZIA, PM
    ALBERTS, DS
    GRAHAM, V
    JONES, SE
    SURWIT, EA
    MOON, TE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 466 - 471
  • [2] DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE - EFFICACY IN CONTROLLING CISPLATIN INDUCED NAUSEA AND VOMITING
    ALLAN, SG
    CORNBLEET, MA
    WARRINGTON, PS
    GOLLAND, IM
    LEONARD, RCF
    SMYTH, JF
    [J]. BRITISH MEDICAL JOURNAL, 1984, 289 (6449) : 878 - 879
  • [3] LORAZEPAM - A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY OF A NEW ANTIEMETIC IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY AND PROCHLORPERAZINE
    BISHOP, JF
    OLVER, IN
    WOLF, MM
    MATTHEWS, JP
    LONG, M
    BINGHAM, J
    HILLCOAT, BL
    COOPER, IA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) : 691 - 695
  • [4] ANTI-EMETIC EFFICACY OF DEXAMETHASONE THERAPY IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
    CASSILETH, PA
    LUSK, EJ
    TORRI, S
    DINUBILE, N
    GERSON, SL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (07) : 1347 - 1349
  • [5] MITOMYCIN-C - REVIEW
    CROOKE, ST
    BRADNER, WT
    [J]. CANCER TREATMENT REVIEWS, 1976, 3 (03) : 121 - 139
  • [6] Daniels M, 1982, Oncol Nurs Forum, V9, P20
  • [7] LORAZEPAM AS AN ADJUNCT TO ANTI-EMETIC THERAPY WITH HALOPERIDOL IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY
    FRIEDLANDER, ML
    KEARSLEY, JH
    SIMS, K
    COATES, A
    HEDLEY, D
    RAGHAVAN, D
    FOX, RM
    TATTERSALL, MHN
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1983, 13 (01): : 53 - 56
  • [8] DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC FOR PATIENTS RECEIVING CANCER-CHEMOTHERAPY - COMPARISON WITH PROCHLORPERAZINE AND A PLACEBO
    FRYTAK, S
    MOERTEL, CG
    OFALLON, JR
    RUBIN, J
    CREAGAN, ET
    OCONNELL, MJ
    SCHUTT, AJ
    SCHWARTAU, NW
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) : 825 - 830
  • [9] A RANDOMIZED TRIAL OF METOCLOPRAMIDE AND A COMBINATION OF DEXAMETHASONE AND LORAZEPAM FOR PREVENTION OF CHEMOTHERAPY-INDUCED VOMITING
    GAGEN, M
    GOCHNOUR, D
    YOUNG, D
    GAGINELLA, T
    NEIDHART, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) : 696 - 701
  • [10] GOSLIN RH, 1981, TREATMENT CANCER CHE, P159
123